C. Jorup

Publications33
h-index13
Citations1,297
Highly Influential Citations67
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • P. O'Byrne
  • 632 Publications, 43,099 Citations
  • H. Reddel
  • 305 Publications, 8,578 Citations
  • E. Bateman
  • 474 Publications, 29,618 Citations
  • P. Barnes
  • 2,007 Publications, 154,027 Citations
  • Publications
  • Influence
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations
This randomised, double‐blind, 6‐month study compared budesonide/formoterol for maintenance and relief with salmeterol/fluticasone and a fixed maintenance dose of budesonide/formoterol, both with… Expand
  • 206
  • 17
  • PDF
As‐Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
Background Patients with mild asthma often rely on inhaled short‐acting β2‐agonists for symptom relief and have poor adherence to maintenance therapy. Another approach might be for patients to… Expand
  • 170
  • 11
Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma
Background In patients with mild asthma, as‐needed use of an inhaled glucocorticoid plus a fast‐acting β2‐agonist may be an alternative to conventional treatment strategies. Methods We conducted a… Expand
  • 191
  • 8
  • PDF
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.
STUDY OBJECTIVE To compare a novel asthma management strategy--budesonide/formoterol in a single inhaler for both maintenance therapy and symptom relief--with a higher dose of budesonide plus… Expand
  • 210
  • 8
  • PDF
Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma
SUMMARY Background: Current asthma guidelines recommend that patients are educated to adjust their medication according to their asthma severity using physician-guided self-management plans. However,… Expand
  • 129
  • 7
Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone.
BACKGROUND Concerns remain about the safety of adding long-acting β2-agonists to inhaled glucocorticoids for the treatment of asthma. In a postmarketing safety study mandated by the Food and Drug… Expand
  • 72
  • 2
  • PDF
Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma 1
We aimed to compare the efficacy and safety of budesonide/formoterol (Symbicort®) with budesonide alone (Pulmicort®) or budesonide (Pulmicort) and formoterol (Oxis®) administered via separate… Expand
  • 53
  • 2
Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
Asthma control is often suboptimal in adolescents, but few studies have evaluated asthma treatments in this population. This post hoc analysis assessed the efficacy and safety of… Expand
  • 20
  • 2
Eff ect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations : a randomised controlled , double-blind study
Background The contributions of as-needed inhaled corticosteroids and long-acting β2 agonists (LABA) to asthma control have not been fully established. We compared the effi cacy and safety of three… Expand
  • 14
  • 2
  • PDF
Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of…
BACKGROUND Prevention of exacerbations is a primary goal for chronic obstructive pulmonary disease (COPD) therapy. This randomized, double-blind, double-dummy, parallel-group, multicenter study… Expand
  • 29
  • 1